SVF ENDURANCE (CAYMAN) LTD sold 1.3% of their position (189.43K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $1.21M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/1/2025ACC: 0001493152-25-025571
10% Owner
Since Oct 2019
-189.43K
Net shares
Net seller
$1.21M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
189.43K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−127.94K
Price / share
$6.39
Trade value
$817.65K
% of position
0.9%
11/26/2025
14.11M→13.98M
Common Stock
Indirect
Shares
−61.49K
Price / share
$6.44
Trade value
$396.01K
% of position
0.4%
11/28/2025
13.98M→13.92M
Total
Net shares
−189.43K
Net value
-$1.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/26/2025 | S · Sale | −127.94K | $6.39 | $817.65K | 0.9% | 14.11M | 13.98M |
| Common Stock Indirect | 11/28/2025 | S · Sale | −61.49K | $6.44 | $396.01K | 0.4% | 13.98M | 13.92M |
| Total | −189.43K | -$1.21M | ||||||
Derivative Transactions0
No derivative transactions reported